Skip to main content

Table 1 Antimicrobial agents and MIC breakpoints for rapidly growing mycobacteria

From: Antimicrobial susceptibility testing of rapidly growing mycobacteria isolated in Japan

Antimicrobial agents

MICa (μg/mL) for category

Susceptible

Intermediate

Resistant

Amikacin

≤16

32

≥64

Tobramycin

≤2

4

≥8

Tigecycline

≤4

 

>4

Minocycline

≤1

2–4

≥8

Ciprofloxacin

≤1

2

≥4

Moxifloxacin

≤1

2

≥4

Clarithromycin

≤2

4

≥8

Linezolid

≤8

16

≥32

Imipenem

≤4

8–16

≥32

Meropenem

≤4

8–16

≥32

Sulfamethoxazole

≤38

 

≥76

  1. Abbreviation MIC minimal inhibitory concentration
  2. aBreakpoints of each drug, except for tigecycline, are based on the Clinical and Laboratory Standards Institute recommendations. Breakpoints for tigecycline were based on those proposed by Petrini [17]
Back to article page

BMC Infectious Diseases

ISSN: 1471-2334

Contact us